What facilitates hepatitis B and hepatitis C testing and the role of stigma among primary care patients in China?
Approximately 80% of primary healthcare facilities in China were ready to deliver hepatitis
care services by 2021. This study aimed to assess hepatitis B and C test uptake, identify the …
care services by 2021. This study aimed to assess hepatitis B and C test uptake, identify the …
Treatment rates and factors associated with direct‐acting antiviral therapy for insured patients with hepatitis C‐related hepatocellular carcinoma–A real‐world …
Background Since the inception of the interferon‐free direct‐acting antiviral agents (DAAs)
for hepatitis C virus (HCV) infection, guidelines as to who should receive this potentially …
for hepatitis C virus (HCV) infection, guidelines as to who should receive this potentially …
Treatment initiation rates of patients with positive anti-hepatitis C virus results in tertiary hospitals in Turkey
M Çelen, B Şengel, Ş Kaya… - Journal of Infection …, 2024 - avesis.marmara.edu.tr
Introduction: The aim of this national, multicenter, cross-sectional, retrospective chart review
study was to determine the proportion of patients in Turkey who received hepatitis C virus …
study was to determine the proportion of patients in Turkey who received hepatitis C virus …
[PDF][PDF] Awareness of chronic hepatitis C in the Western Black Sea Region.
Z SARGIN - European Review for Medical & Pharmacological …, 2022 - europeanreview.org
OBJECTIVE: Chronic hepatitis C (CHC) can be cured with oral antivirals. Awareness of CHC
is a substantial barrier to the World Health Organization's goal of eradicating HCV by 2030 …
is a substantial barrier to the World Health Organization's goal of eradicating HCV by 2030 …
Are We Aware of Hepatitis C Infection? HCV Results from the Tertiary Reference Center in the Aegean Region from Turkey
G Derviş Hakim, P Şamlıoglu, M Aysin… - … Journal of Clinical …, 2024 - Wiley Online Library
Background. With the advent of direct‐acting antiviral agents, the rate of sustained
virological response in the treatment of hepatitis C virus (HCV) infection has reached 100 …
virological response in the treatment of hepatitis C virus (HCV) infection has reached 100 …
Assessment of HCV-RNA test results and access rates to antiviral treatment in patients with anti-HCV positivity-a 10-year analysis
E Türkoğlu, Z Parlak, HŞ Barut - Turkish journal of medical …, 2022 - journals.tubitak.gov.tr
Background/aim: Currently, hepatitis C virus (HCV) infection can be cured by direct-acting
antivirals (DAAs). In this study, we aimed to find the rate of viremia among patients with a …
antivirals (DAAs). In this study, we aimed to find the rate of viremia among patients with a …
Anti-hcv bakılan olgularda hcv-rna sonuçlarının değerlendirilmesi
F Gönan - 2023 - acikerisim.erbakan.edu.tr
Özet Bu çalışmada anti-HCV pozitif olan hastalarda HCV-RNA istenme oranı ve pozitifliğinin
belirlenmesi, anti-HCV pozitifliği saptandıktan sonra HCV-RNA bakılmayan hastaların …
belirlenmesi, anti-HCV pozitifliği saptandıktan sonra HCV-RNA bakılmayan hastaların …
Treatment initiation rates of patients with positive anti-hepatitis C virus results in tertiary hospitals in Turkey: a retrospective, cross-sectional chart review (Lost-C Study)
MK Çelen, BE Şengel, Ş Kaya, N Demirtürk, A Azap… - 2022 - researchsquare.com
Background: The aim of this national, multicenter, cross-sectional, retrospective chart review
study was to determine the rate of patients in Turkey who received hepatitis C virus (HCV) …
study was to determine the rate of patients in Turkey who received hepatitis C virus (HCV) …
[引用][C] Evaluation of patients whose HCV serology was investigated in our hospital between 2010-2018
H Tünay, N Demirtürk - 2022 - Effect Publishing Agency (EPA)
[引用][C] 1 Ocak 2010–31 Aralık 2021 tarihleri arasında Bursa Uludağ Üniversitesi Tıp Fakültesinde anti-HCV pozitifliği saptanan olguların retrospektif değerlendirilmesi
RA Özer - 2024 - Bursa Uludağ Üniversitesi